Study of ATI-1013 in healthy smokers who want to quit
Treatments studied
Part of Heart & circulation, Mental health clinical trials.
This trial tests a new drug called ATI-1013 in healthy smokers. It aims to see how safe the drug is and how it works in the body. If you smoke at least 10 cigarettes a day and are in good health, you might be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 23 and 59 years old.
- You must be a current smoker of at least 10 cigarettes a day for 2 years or more.
- You must be in good general health with no serious medical conditions.
- You must not have used any other smoking cessation treatments in the last 90 days.
- Women must not be pregnant or planning pregnancy and must use birth control during the study.
- You must avoid all tobacco and nicotine products for certain periods during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This first-in-human study tests the safety of a new medicine called VNT-101. Healthy adults aged 18 to 59 who do not smoke and have no major health problems may be able to join. The goal is to see how the body handles the drug and if it is safe.
This study tests how much people might want to use five different types of modern oral nicotine products (like pouches or lozenges) compared to smoking their usual cigarette. It helps researchers understand if these products could be less addictive than cigarettes.
This early-phase trial tests an experimental oral medication called FB-101 in healthy adult men to check its safety and how the body processes it. It's a first step to see if the drug is safe enough for future studies in patients.
This study tests how appealing and potentially habit-forming heated tobacco products are for current smokers. You would stay in a clinic for 10 days, smoke your usual cigarettes, and also use heated tobacco devices and nicotine gum.
This trial tests an injectable drug called brenipatide to see if it helps people who have recently quit smoking stay quit for good. The study follows participants over time and requires them to come to clinic visits.
This study looks at whether switching from regular cigarettes to a tobacco heating product slows buildup of plaque in the heart arteries. You’d be guided through smoking change and monitored using heart scans, to see if artery plaque stays the same or improves.
Hear when a new Thromboangiitis Obliterans (Buerger's Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.